Skip to main content
Year archive

Vivesto — 2019 filings

All 224 regulatory filings released by Vivesto (VIVE) in 2019, sourced directly from the official regulator.

224 Filings
2019 Period
2019 filings (224)
Filing Released Lang
New number of shares and votes in Oasmia Pharmaceutical AB (publ)
Share Issue/Capital Change
2019-12-30 English
Nytt antal aktier och röster i Oasmia Pharmaceutical AB (publ)
Share Issue/Capital Change
2019-12-30 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2019-12-30 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report H2 2019
2019-12-30 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-12-20 English
Slutligt utfall i Oasmias företrädesemission
Capital/Financing Update
2019-12-09 Swedish
Final result of the rights issue in Oasmia
Capital/Financing Update
2019-12-09 English
Oasmias företrädesemission övertecknad
Capital/Financing Update
2019-12-09 Swedish
Oasmia’s rights issue has been oversubscribed
Share Issue/Capital Change
2019-12-09 English
Oasmia offentliggör prospekt i samband med företrädesemission om cirka 399 MSEK samt uppdaterad information som återfinns i prospektet
Capital/Financing Update
2019-11-19 Swedish
Oasmia publishes prospectus in connection with the rights issue of approximately SEK 399 million and updated information included in the prospectus
Capital/Financing Update
2019-11-19 English
Oasmia beslutar om en företrädesemission om cirka 399 MSEK
Share Issue/Capital Change
2019-11-11 Swedish
Oasmia resolves on a rights issue of approximately SEK 399 million
Capital/Financing Update
2019-11-11 English
Extraordinary General Meeting in Oasmia Pharmaceutical AB on November 6, 2019
AGM Information
2019-11-06 English
Extra bolagsstämma i Oasmia Pharmaceutical AB den 6 november 2019
AGM Information
2019-11-06 Swedish
Oasmia recruits Michael of Winklerfelt as new CFO
Board/Management Information
2019-10-30 English
Oasmia rekryterar Michael af Winklerfelt som ny CFO
Board/Management Information
2019-10-30 Swedish
Kallelse till extra bolagsstämma i Oasmia Pharmaceutical AB
AGM Information
2019-10-14 Swedish
Notice of extraordinary general meeting in Oasmia Pharmaceutical AB
AGM Information
2019-10-14 English
The Board of Directors in Oasmia proposes a rights issue of approximately SEK 400 million
Capital/Financing Update
2019-10-14 English
Kallelse till extra bolagsstämma i Oasmia Pharmaceutical AB
AGM Information
2019-10-14 Swedish
Notice of extraordinary general meeting in Oasmia Pharmaceutical AB
AGM Information
2019-10-14 English
The Board of Directors in Oasmia proposes a rights issue of approximately SEK 400 million
Share Issue/Capital Change
2019-10-14 English
Styrelsen i Oasmia föreslår en företrädesemission om cirka 400 MSEK
Share Issue/Capital Change
2019-10-14 Swedish
Årsstämma i Oasmia Pharmaceutical AB den 26 september 2019
AGM Information
2019-09-26 Swedish
Annual General Meeting in Oasmia Pharmaceutical AB on September 26, 2019
AGM Information
2019-09-26 English
Annual General Meeting in Oasmia Pharmaceutical AB on September 26, 2019
AGM Information
2019-09-26 English
Årsstämma i Oasmia Pharmaceutical AB den 26 september 2019
AGM Information
2019-09-26 Swedish
Oasmia Pharmaceutical AB (publ) Interim report for the period May 1 – July 31, 2019
Interim / Quarterly Report Q1 2019
2019-09-26 English
Oasmia Pharmaceutical AB (publ) Delårsrapport för perioden 1 maj – 31 juli 2019
Report Publication Announcement Q1 2019
2019-09-26 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q3 2019
2019-09-26 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q2 2019
2019-09-26 English
Oasmia offentliggör rapport avseende särskild utredning av ansvarsfrågor genomförd av revisionsbyrån Deloitte
Audit Report / Information FY 2019
2019-09-18 Swedish
Oasmia publishes report on special investigation of liability issues conducted by audit firm Deloitte
AGM Information
2019-09-18 English
Oasmia offentliggör rapport avseende särskild utredning av ansvarsfrågor genomförd av revisionsbyrån Deloitte
Audit Report / Information FY 2019
2019-09-18 Swedish
Oasmia offentliggör rapport avseende särskild utredning av ansvarsfrågor genomförd av revisionsbyrån Deloitte
Audit Report / Information FY 2019
2019-09-18 Swedish
Oasmia offentliggör rapport avseende särskild utredning av ansvarsfrågor genomförd av revisionsbyrån Deloitte
Audit Report / Information FY 2019
2019-09-18 Swedish
Oasmia publishes report on special investigation of liability issues conducted by audit firm Deloitte
AGM Information
2019-09-18 English
Oasmia publishes report on special investigation of liability issues conducted by audit firm Deloitte
AGM Information
2019-09-18 English
Oasmia publishes report on special investigation of liability issues conducted by audit firm Deloitte
AGM Information
2019-09-18 English
Oasmia presents Q1 report through audiocast on September 26
Report Publication Announcement
2019-09-18 English
Oasmia presents Q1 report through audiocast on September 26
Report Publication Announcement
2019-09-18 English
Oasmia presents Q1 report through audiocast on September 26
Report Publication Announcement
2019-09-18 English
Oasmia presents Q1 report through audiocast on September 26
Report Publication Announcement
2019-09-18 English
Oasmia publishes report on special investigation of liability issues conducted by audit firm Deloitte
Governance Information
2019-09-18 English
Oasmia offentliggör rapport avseende särskild utredning av ansvarsfrågor genomförd av revisionsbyrån Deloitte
Governance Information
2019-09-18 Swedish
Valberedningens förslag till styrelse och revisor för Oasmia Pharmaceutical AB inför årsstämman 2019
Board/Management Information
2019-09-15 Swedish
The Nomination Committee's proposal regarding Board of Directors and auditor of Oasmia Pharmaceutical AB for AGM 2019
AGM Information
2019-09-15 English
The Nomination Committee's proposal regarding Board of Directors and auditor of Oasmia Pharmaceutical AB for AGM 2019
AGM Information
2019-09-15 English
Valberedningens förslag till styrelse och revisor för Oasmia Pharmaceutical AB inför årsstämman 2019
Board/Management Information
2019-09-15 Swedish
Valberedningens förslag till styrelse och revisor för Oasmia Pharmaceutical AB inför årsstämman 2019
AGM Information
2019-09-15 Swedish
The Nomination Committee's proposal regarding Board of Directors and auditor of Oasmia Pharmaceutical AB for AGM 2019
Board/Management Information
2019-09-15 English
Oasmia publishes its annual report and adjusts accounts due to write-downs - auditors do not recommend former board to be granted discharge from liability
Report Publication Announcement
2019-09-05 English
Oasmia publishes its annual report and adjusts accounts due to write-downs - auditors do not recommend former board to be granted discharge from liability
Report Publication Announcement
2019-09-05 English
Oasmia offentliggör årsredovisning och reviderar räkenskaper efter nedskrivningar - revisor avstyrker beviljandet av ansvarsfrihet för tidigare styrelse
Report Publication Announcement
2019-09-05 Swedish
Oasmia offentliggör årsredovisning och reviderar räkenskaper efter nedskrivningar - revisor avstyrker beviljandet av ansvarsfrihet för tidigare styrelse
Report Publication Announcement
2019-09-05 Swedish
Oasmia offentliggör årsredovisning och reviderar räkenskaper efter nedskrivningar - revisor avstyrker beviljandet av ansvarsfrihet för tidigare styrelse
Report Publication Announcement
2019-09-05 Swedish
Oasmia publishes its annual report and adjusts accounts due to write-downs - auditors do not recommend former board to be granted discharge from liability
Report Publication Announcement
2019-09-05 English
Oasmia publishes its annual report and adjusts accounts due to write-downs - auditors do not recommend former board to be granted discharge from liability
Report Publication Announcement
2019-09-05 English
Oasmia offentliggör årsredovisning och reviderar räkenskaper efter nedskrivningar - revisor avstyrker beviljandet av ansvarsfrihet för tidigare styrelse
Audit Report / Information FY 2019
2019-09-05 Swedish
Annual Report 2019
Annual Report FY 2019
2019-09-05 Swedish
Annual Report 2019
Annual Report FY 2019
2019-09-05 English
Oasmia completes its management team
Board/Management Information
2019-09-04 English
Oasmia completes its management team
Board/Management Information
2019-09-04 English
Oasmia completes its management team
Board/Management Information
2019-09-04 English
Oasmia completes its management team
Board/Management Information
2019-09-04 English
Notice of Annual General Meeting in Oasmia Pharmaceutical AB
Proxy Solicitation & Information Statement
2019-08-28 English
Kallelse till årsstämma i Oasmia Pharmaceutical AB
AGM Information
2019-08-28 Swedish
Notice of Annual General Meeting in Oasmia Pharmaceutical AB
Proxy Solicitation & Information Statement
2019-08-28 English
Kallelse till årsstämma i Oasmia Pharmaceutical AB
AGM Information
2019-08-28 Swedish
Kallelse till årsstämma i Oasmia Pharmaceutical AB
AGM Information
2019-08-28 Swedish
Notice of Annual General Meeting in Oasmia Pharmaceutical AB
Proxy Solicitation & Information Statement
2019-08-28 English
Notice of Annual General Meeting in Oasmia Pharmaceutical AB
Proxy Solicitation & Information Statement
2019-08-28 English
Kallelse till årsstämma i Oasmia Pharmaceutical AB
AGM Information
2019-08-28 Swedish
Notice of Annual General Meeting in Oasmia Pharmaceutical AB
AGM Information
2019-08-28 English
Kallelse till årsstämma i Oasmia Pharmaceutical AB
AGM Information
2019-08-28 Swedish
Oasmias depåbevis avnoterade från NASDAQ i USA
Delisting Announcement
2019-08-23 Swedish
Oasmias depåbevis avnoterade från NASDAQ i USA
Delisting Announcement
2019-08-23 Swedish
Oasmia ADSs delisted from NASDAQ in the US
Delisting Announcement
2019-08-23 English
Oasmia ADSs delisted from NASDAQ in the US
Delisting Announcement
2019-08-23 English
Oasmia ADSs delisted from NASDAQ in the US
Delisting Announcement
2019-08-23 English
Oasmias depåbevis avnoterade från NASDAQ i USA
Delisting Announcement
2019-08-23 Swedish
Oasmia ADSs delisted from NASDAQ in the US
Delisting Announcement
2019-08-23 English
Oasmias depåbevis avnoterade från NASDAQ i USA
Delisting Announcement
2019-08-23 Swedish
Oasmias depåbevis avnoterade från NASDAQ i USA
Delisting Announcement
2019-08-23 Swedish
Oasmia ADSs delisted from NASDAQ in the US
Delisting Announcement
2019-08-23 English
Nomination committee in Oasmia for the 2019 AGM
Net Asset Value
2019-08-20 English
Valberedning i Oasmia inför årstämma 2019
AGM Information
2019-08-20 Swedish
Valberedning i Oasmia inför årstämma 2019
AGM Information
2019-08-20 Swedish
Nomination committee in Oasmia for the 2019 AGM
Net Asset Value
2019-08-20 English
Valberedning i Oasmia inför årstämma 2019
AGM Information
2019-08-20 Swedish
Nomination committee in Oasmia for the 2019 AGM
Net Asset Value
2019-08-20 English
Nomination committee in Oasmia for the 2019 AGM
Net Asset Value
2019-08-20 English
Valberedning i Oasmia inför årstämma 2019
AGM Information
2019-08-20 Swedish
Nomination committee in Oasmia for the 2019 AGM
Board/Management Information
2019-08-20 English
Valberedning i Oasmia inför årstämma 2019
Board/Management Information
2019-08-20 Swedish
Oasmia senarelägger publiceringen av Q1-rapport till den 26 september samt justerar finansiell kalender
Report Publication Announcement
2019-08-15 Swedish
Oasmia senarelägger publiceringen av Q1-rapport till den 26 september samt justerar finansiell kalender
Report Publication Announcement
2019-08-15 Swedish
Oasmia senarelägger publiceringen av Q1-rapport till den 26 september samt justerar finansiell kalender
Report Publication Announcement
2019-08-15 Swedish
Oasmia postpones the release of the Q1 report to 26 September and adjusts its financial calendar
Report Publication Announcement
2019-08-15 English
Oasmia postpones the release of the Q1 report to 26 September and adjusts its financial calendar
Report Publication Announcement
2019-08-15 English
Oasmia senarelägger publiceringen av Q1-rapport till den 26 september samt justerar finansiell kalender
Report Publication Announcement
2019-08-15 Swedish
Oasmia postpones the release of the Q1 report to 26 September and adjusts its financial calendar
Report Publication Announcement
2019-08-15 English
Oasmia postpones the release of the Q1 report to 26 September and adjusts its financial calendar
Report Publication Announcement
2019-08-15 English
Oasmia senarelägger publiceringen av Q1-rapport till den 26 september samt justerar finansiell kalender
Report Publication Announcement
2019-08-15 Swedish
Oasmia postpones the release of the Q1 report to 26 September and adjusts its financial calendar
Report Publication Announcement
2019-08-15 English
Oasmia intends to delist from NASDAQ in the US to reduce complexity and costs
Delisting Announcement
2019-08-03 English
Oasmia avser att avnoteras från NASDAQ i USA för att minska komplexitet och kostnader
Delisting Announcement
2019-08-03 Swedish
Oasmia intends to delist from NASDAQ in the US to reduce complexity and costs
Delisting Announcement
2019-08-02 English
Oasmia intends to delist from NASDAQ in the US to reduce complexity and costs
Delisting Announcement
2019-08-02 English
Oasmia intends to delist from NASDAQ in the US to reduce complexity and costs
Delisting Announcement
2019-08-02 English
Oasmia intends to delist from NASDAQ in the US to reduce complexity and costs
Delisting Announcement
2019-08-02 English
New number of shares and votes in Oasmia Pharmaceutical AB (publ)
Share Issue/Capital Change
2019-07-31 English
New number of shares and votes in Oasmia Pharmaceutical AB (publ)
Share Issue/Capital Change
2019-07-31 English
New number of shares and votes in Oasmia Pharmaceutical AB (publ)
Share Issue/Capital Change
2019-07-31 English
New number of shares and votes in Oasmia Pharmaceutical AB (publ)
Share Issue/Capital Change
2019-07-31 English
New number of shares and votes in Oasmia Pharmaceutical AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2019-07-31 English
Nytt antal aktier och röster i Oasmia Pharmaceutical AB (publ)
Share Issue/Capital Change
2019-07-31 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-07-17 English
Oasmia discontinues cooperation with former executive chairman
Board/Management Information
2019-07-09 English
Oasmia discontinues cooperation with former executive chairman
Board/Management Information
2019-07-09 English
Oasmia discontinues cooperation with former executive chairman
Board/Management Information
2019-07-09 English
Oasmia and Arwidsro have solved outstanding balances and Arwidsro increases its investment in Oasmia
Capital/Financing Update
2019-07-05 English
Oasmia and Arwidsro have solved outstanding balances and Arwidsro increases its investment in Oasmia
Capital/Financing Update
2019-07-05 English
Oasmia and Arwidsro have solved outstanding balances and Arwidsro increases its investment in Oasmia
Share Issue/Capital Change
2019-07-05 English
Oasmia och Arwidsro har löst utestående mellanhavanden och Arwidsro satsar ytterligare i Oasmia
Capital/Financing Update
2019-07-05 Swedish
Oasmia and Arwidsro have solved outstanding balances and Arwidsro increases its investment in Oasmia
Capital/Financing Update
2019-07-05 English
Oasmia appoints Business Advisory Board
Board/Management Information
2019-07-04 English
Oasmia appoints Business Advisory Board
Board/Management Information
2019-07-04 English
Oasmia appoints Business Advisory Board
Board/Management Information
2019-07-04 English
Oasmia appoints Business Advisory Board
Board/Management Information
2019-07-04 English
Oasmia tillsätter Business Advisory Board
Board/Management Information
2019-07-04 Swedish
Oasmia appoints Scientific Advisory Board
Board/Management Information
2019-07-02 English
Oasmia appoints Scientific Advisory Board
Board/Management Information
2019-07-02 English
Oasmia appoints Scientific Advisory Board
Board/Management Information
2019-07-02 English
Oasmia appoints new CMO
Board/Management Information
2019-07-02 English
Oasmia appoints new CMO
Board/Management Information
2019-07-02 English
Oasmia appoints new CMO
Board/Management Information
2019-07-02 English
Oasmia tillsätter Scientific Advisory Board
Board/Management Information
2019-07-02 Swedish
Oasmia appoints Scientific Advisory Board
Board/Management Information
2019-07-02 English
Oasmia announces change of CEO
Board/Management Information
2019-06-28 English
Oasmia announces change of CEO
Board/Management Information
2019-06-28 English
The Board of Oasmia has decided to report certain transactions to the Swedish Economic Crime Authority and to appoint a special examiner
Legal Proceedings Report
2019-06-28 English
The Board of Oasmia has decided to report certain transactions to the Swedish Economic Crime Authority and to appoint a special examiner
Legal Proceedings Report
2019-06-28 English
The Board of Oasmia has decided to report certain transactions to the Swedish Economic Crime Authority and to appoint a special examiner
Legal Proceedings Report
2019-06-28 English
Oasmia Pharmaceutical AB (publ) Year-end report for the financial year May 1, 2018 – April 30, 2019
Interim / Quarterly Report Q4 2019
2019-06-28 English
Oasmia announces change of CEO
Board/Management Information
2019-06-28 English
Oasmia Pharmaceutical AB (publ) Year-end report for the financial year May 1, 2018 – April 30, 2019
Interim / Quarterly Report Q4 2019
2019-06-28 English
Oasmia Pharmaceutical AB (publ) Year-end report for the financial year May 1, 2018 – April 30, 2019
AGM Information
2019-06-28 English
Interim / Quarterly Report 2019
Interim / Quarterly Report FY 2019
2019-06-28 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report FY 2019
2019-06-28 English
Styrelsen har beslutat att anmäla vissa transaktioner i Oasmia till Ekobrottsmyndigheten samt har utsett en särskild granskningsman
Legal Proceedings Report
2019-06-28 Swedish
Oasmia announces change of CEO
Board/Management Information
2019-06-28 English
Oasmia presents full-year report and status in the Board's review through audiocast on June 28
Report Publication Announcement
2019-06-26 English
Oasmia presents full-year report and status in the Board's review through audiocast on June 28
Report Publication Announcement
2019-06-26 English
Oasmia presents full-year report and status in the Board's review through audiocast on June 28
Report Publication Announcement
2019-06-26 English
Two studies finalized in Oasmia Pharmaceutical’s Docecal programme
Regulatory Filings
2019-06-25 English
Two studies finalized in Oasmia Pharmaceutical’s Docecal programme
Regulatory Filings
2019-06-25 English
Two studies finalized in Oasmia Pharmaceutical’s Docecal programme
Regulatory Filings
2019-06-25 English
Två studier genomförda i Oasmia Pharmaceuticals Docecal-program
Earnings Release FY 2019
2019-06-25 Swedish
Two studies finalized in Oasmia Pharmaceutical’s Docecal programme
Regulatory Filings
2019-06-25 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-06-12 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-06-04 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-05-21 English
Oasmia postpones the release of the Q4 and year-end report to 28 June
Report Publication Announcement
2019-05-15 English
Oasmia senarelägger publiceringen av Q4-rapporten och bokslutskommunikén till den 28 juni
Report Publication Announcement
2019-05-15 Swedish
Oasmia postpones the release of the Q4 and year-end report to 28 June
Report Publication Announcement
2019-05-15 English
Oasmia expands the Management Team
Board/Management Information
2019-04-10 English
Short report of the status of the review in Oasmia
AGM Information
2019-04-03 English
Ökning av antalet aktier och röster i Oasmia Pharmaceutical AB (publ)
Share Issue/Capital Change
2019-03-29 Swedish
Increase in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
Share Issue/Capital Change
2019-03-29 English
The results from Oasmia Pharmaceuticals first study with paclitaxel micellar in humans are published in the scientific journal ”Advances in Therapy”.
Report Publication Announcement
2019-03-28 English
Resultaten från Oasmia Pharmaceuticals första studie med paklitaxel micellär i människa publiceras i den vetenskapliga tidskriften ”Advances in Therapy”.
Regulatory Filings
2019-03-28 Swedish
The results from Oasmia Pharmaceuticals first study with paclitaxel micellar in humans are published in the scientific journal ”Advances in Therapy”.
Regulatory Filings
2019-03-28 English
Notification from Oasmia Pharmaceutical AB
Legal Proceedings Report
2019-03-26 English
CFO of Oasmia, Anders Blom has resigned
Board/Management Information
2019-03-26 English
CFO of Oasmia, Anders Blom has resigned
Board/Management Information
2019-03-26 English
Oasmias CFO Anders Blom har sagt upp sig
Board/Management Information
2019-03-26 Swedish
Oasmia Pharmaceutical AB receives positive opinion from the European Medicines Agency to add efficacy data to the approved Apealea® product information
Regulatory Filings
2019-03-25 English
Oasmia Pharmaceutical AB receives positive opinion from the European Medicines Agency to add efficacy data to the approved Apealea® product information
Legal Proceedings Report
2019-03-25 English
Oasmia Pharmaceutical AB har erhållit ett positivt utlåtande från Europeiska läkemedelsmyndigheten för att lägga till effektresultat till den godkända produktinformationen för Apealea®
Regulatory Filings
2019-03-25 Swedish
New Board starts reviewing the situation in Oasmia
AGM Information
2019-03-21 English
New Board starts reviewing the situation in Oasmia
Board/Management Information
2019-03-21 English
Nya styrelsen inleder sin genomlysning av situationen i Oasmia
Board/Management Information
2019-03-21 Swedish
Oasmia Pharmaceutical AB (publ): Press release from the extraordinary general meeting 19 March 2019
AGM Information
2019-03-19 English
Oasmia Pharmaceutical AB (publ): Kommuniké från extra bolagsstämma den 19 mars 2019
AGM Information
2019-03-19 Swedish
Oasmia Pharmaceutical AB (publ): Press release from the extraordinary general meeting 19 March 2019
AGM Information
2019-03-19 English
Oasmia announces a prospectus regarding admission to trading of new shares
Report Publication Announcement
2019-03-18 English
Oasmia announces a prospectus regarding admission to trading of new shares
Share Issue/Capital Change
2019-03-18 English
Oasmia offentliggör prospekt avseende upptagande till handel av nya aktier
Report Publication Announcement
2019-03-18 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-03-12 English
Oasmia Pharmaceutical Strengthens its Management Team and Organization
Board/Management Information
2019-03-06 English
Oasmia Pharmaceutical förstärker ledningsgruppen och stärker organisationen
Board/Management Information
2019-03-06 Swedish
Oasmia Pharmaceutical Strengthens its Management Team and Organization
Board/Management Information
2019-03-06 English
Oasmia har genomfört en riktad nyemission om cirka 165 MSEK
Share Issue/Capital Change
2019-03-04 Swedish
Oasmia has completed a directed share issue of approximately 165 MSEK
Share Issue/Capital Change
2019-03-04 English
Oasmia has completed a directed share issue of approximately 165 MSEK
Share Issue/Capital Change
2019-03-04 English
Oasmia Pharmaceutical AB (publ)
Interim / Quarterly Report 9M 2019
2019-03-01 English
Interim / Quarterly Report 2019
Interim / Quarterly Report 9M 2019
2019-03-01 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report 9M 2019
2019-03-01 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-26 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-12 English
NOTICE OF EXTRAORDINARY GENERAL MEETING IN OASMIA PHARMACEUTICAL AB (PUBL) - UPDATED VERSION
AGM Information
2019-02-05 English
NOTICE OF EXTRAORDINARY GENERAL MEETING IN OASMIA PHARMACEUTICAL AB (PUBL) - UPDATED VERSION
AGM Information
2019-02-05 English
KALLELSE TILL EXTRA BOLAGSSTÄMMA I OASMIA PHARMACEUTICAL AB (PUBL) - UPPDATERAD VERSION
AGM Information
2019-02-05 Swedish
NOTICE OF EXTRAORDINARY GENERAL MEETING IN OASMIA PHARMACEUTICAL AB (PUBL)
AGM Information
2019-02-05 English
Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
Share Issue/Capital Change
2019-01-31 English
Ändring av antalet aktier och röster i Oasmia Pharmaceutical AB (publ)
Share Issue/Capital Change
2019-01-31 Swedish
Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
Share Issue/Capital Change
2019-01-31 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-29 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-23 English
Oasmia Pharmaceutical AB’s (publ, ”Oasmia”) decision to cancel the extraordinary general meeting on January 25, 2019
Legal Proceedings Report
2019-01-22 English
Oasmia Pharmaceutical AB:s (publ, ”Oasmia”) beslut att ställa in den extra bolagsstämman den 25 januari 2019
Regulatory Filings
2019-01-22 Swedish
Oasmia Pharmaceutical AB’s (publ, ”Oasmia”) decision to cancel the extraordinary general meeting on January 25, 2019
Regulatory Filings
2019-01-22 English
Oasmia announces that the extraordinary general meeting 25 January 2019 is cancelled
Regulatory Filings
2019-01-21 English
Oasmia announces that the extraordinary general meeting 25 January 2019 is cancelled
Delisting Announcement
2019-01-21 English
Oasmia meddelar att den extra bolagsstämman den 25 januari 2019 ställs in
AGM Information
2019-01-21 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-15 English
European Medicines Agency validates Oasmia Pharmaceutical AB’s application to add efficacy data to the approved Apealea® product information
Regulatory Filings
2019-01-15 English
Europeiska läkemedelsmyndigheten (EMA) har validerat Oasmia Pharmaceutical AB’s ändringsansökan om att lägga till effektresultat till den godkända produktinformationen för Apealea®
Regulatory Filings
2019-01-15 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-14 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-11 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-10 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-09 English